Subsequently, somatic mutations of JAK2 exon 12 are found in most PV patients without JAK2V617F mutation [3,4], whereas the thrombopoietin receptor (MPL) mutations are present in a small number of patients with ET or PMF [5,6]. Here, MPL is linked to essential thrombocythemia.